‹ All stocks
LTGO
Latigo Biotherapeutics
LTGO · NASDAQ · Healthcare
$16.33
▼ $16.33 (-2.77%)
Day range
$16.25 – $16.90
Year range
$16.19 – $25.93
Open
$16.80
Previous close
—
Market cap
$982.58M
Volume (24h)
$57.0K
Volume (52w)
$930.64K
Performance
7D
▼ -6.55%
1M
▼ -24.97%
3M
▼ -10.49%
6M
▼ -10.49%
1Y
▼ -10.49%
YTD
▼ -10.49%
3Y
▼ -10.49%
5Y
▼ -10.49%
All-time
▼ -10.49%
Key statistics
P/E ratio
-25.13
EPS (TTM)
$-0.65
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
60.2M
About Latigo Biotherapeutics
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1139.65 | -1.23% |
JNJ Johnson & Johnson |
$256.11 | -1.42% |
ABBV AbbVie |
$260.91 | 0.45% |
MRK Merck & Co. |
$143.38 | -0.27% |
UNH UnitedHealth Group Incorp… |
$368.09 | 0.81% |